Abstract
It has been a retrospective review of healing of bone defects, due to benign tumours or tumour-like lesions. We evaluated the therapeutical outcome in patients after use of either autologous bone grafts, or β-tricalcium phosphate (β-TCP), or mixture of both components.
We tried to find indications for β-TCP application.